OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
109
Results
Show all
Save search
Copy query
Show results for
Unknown
(107)
Transcriptomics
(1)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Listeria phage A118
(1)
Synechococcus phage syn9
(1)
Mucilaginibacter
(1)
NEWT:10699
(1)
Pedobacter sp.
(1)
Clostridium phage c-st
(1)
Luteibacter
(1)
Synechococcus phage S-SSM7
(1)
Mycobacterium
(1)
Influenza A virus (H1N1)
(1)
environmental samples
(1)
Schizosaccharomyces pombe DM3650
(1)
Novosphingobium nitrogenifigens
(1)
environmental samples
(1)
Acipenser transmontanus
(1)
Rhizobium cf. leguminosarum
(1)
Tequatrovirus T4
(1)
Muvirus mu
(1)
Mycoplasmopsis agalactiae
(1)
Coffea eugenioides
(1)
Salmonella sp. ZZ-4
(1)
Cryptochiton stelleri
(1)
Methylomicrobium album BG8
(1)
Crenomytilus
(1)
Severe acute respiratory syndrome coronavirus
(1)
Orthohepacivirus
(1)
Roseburia inulinivorans DSM 16841
(1)
Bifidobacterium adolescentis ATCC 15703
(1)
Murine norovirus 1
(1)
Repository
biostudies-arrayexpress
(1)
pride
(1)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Disease
Breast cancer
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2011
(1)
2022
(1)
Study type
Transcription profiling by array
(1)
Release Date
2025
(14)
2021
(13)
2023
(10)
2022
(10)
2024
(9)
2019
(9)
2020
(7)
2014
(7)
2018
(5)
2015
(5)
2011
(4)
2026
(4)
2012
(3)
2013
(2)
2010
(2)
2009
(2)
2016
(1)
2008
(1)
Lab affiliation
Division of Surgery and Cancer Imperial College, London
(1)
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.
Not available
S-EPMC4417726
|
biostudies-literature
Cite
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.
Not available
S-EPMC3236655
|
biostudies-literature
Cite
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.
Not available
S-EPMC5933261
|
biostudies-literature
Cite
Molecular insight of regorafenib treatment for colorectal cancer.
Not available
S-EPMC7491975
|
biostudies-literature
Cite
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer.
Not available
S-EPMC8727586
|
biostudies-literature
Cite
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer.
Not available
S-EPMC12047410
|
biostudies-literature
Cite
Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancer.
Not available
S-EPMC12596543
|
biostudies-literature
Cite
Molecular Characterization of Appendiceal Goblet Cell Carcinoid.
Not available
S-EPMC8011958
|
biostudies-literature
Cite
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer.
Not available
S-EPMC11442451
|
biostudies-literature
Cite
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer.
Not available
S-EPMC7656952
|
biostudies-literature
Cite
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
